+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ambisome"

From
Cryptococcal Meningitis - Pipeline Insight, 2024 - Product Thumbnail Image

Cryptococcal Meningitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Ambisome - API Insight, 2022 - Product Thumbnail Image

Ambisome - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Ambisome- Drug Insight, 2019 - Product Thumbnail Image

Ambisome- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Ambisome is a brand of liposomal amphotericin B, an antifungal drug used to treat a variety of fungal infections. It is used to treat serious fungal infections in patients with weakened immune systems, such as those with HIV/AIDS, cancer, or organ transplants. Ambisome is a polyene antifungal drug, meaning it works by binding to the cell membrane of the fungus and disrupting its structure. It is generally used as a last resort when other antifungal drugs have failed. Ambisome is part of the larger Infectious Diseases Drugs market, which includes a variety of drugs used to treat bacterial, viral, and fungal infections. These drugs are used to treat a wide range of infections, from common colds to life-threatening illnesses. Some companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, AstraZeneca, and Novartis. Show Less Read more